ホーム>>Natural Products>>Herniarin (7-Methoxycoumarin)

Herniarin (7-Methoxycoumarin) (Synonyms: Ayapanin, Gerniarin, Herniarin, Methylumbelliferone, NSC 404559)

カタログ番号GC34148

ヘルニアリン (7-Methoxycoumarin) は、一部の開花植物に含まれる天然のクマリンで、抗腫瘍効果があります。

Products are for research use only. Not for human use. We do not sell to patients.

Herniarin (7-Methoxycoumarin) 化学構造

Cas No.: 531-59-9

サイズ 価格 在庫数 個数
10mM (in 1mL DMSO)
$24.00
在庫あり
100mg
$22.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Herniarin is a natural coumarin occurs in some flowering plants, with antitumor effect.

Herniarin is cytotoxic to breast carcinoma cell line MCF-7 with an IC50 of 207.6 µM. Herniarin (100 µM) also induces apoptosis in MCF-7 cells[1]. Herniarin alone has no obvious cytotoxicity on transitional cell carcinoma (TCC) cells, but when in combination with 5 µg/mL cisplatin, Herniarin (80 µg/mL) potently enhances the antitumor effect of cisplatin, and increases chromatin condensation[2].

[1]. Mousavi SH, et al. Comparative analysis of the cytotoxic effect of 7-prenyloxycoumarin compounds and herniarin on MCF-7 cell line. Avicenna J Phytomed. 2015 Nov-Dec;5(6):520-30. [2]. Haghighitalab A, et al. Enhancement of cisplatin cytotoxicity in combination with herniarin in vitro. Drug Chem Toxicol. 2014 Apr;37(2):156-62.

レビュー

Review for Herniarin (7-Methoxycoumarin)

Average Rating: 5 ★★★★★ (Based on Reviews and 5 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Herniarin (7-Methoxycoumarin)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.